Healthium Medtech acquires controlling stake in Paramount Surgimed

image credit- freepik

Bengaluru-based Healthium Medtech is acquiring a controlling stake in Paramount Surgimed, one of India’s largest manufacturers and exporters of surgical blades, scalpels and dermal biopsy products. The non-surgical business of Paramount, including its lifestyle and hygiene business will be carved out prior to the transaction and retained with the Grover family.

With this move, Healthium will expand its specialised presence in the surgical consumables segment, where Paramount’s blades and dermal biopsy categories represent a logical extension of its existing business line. This alignment creates a two-way synergy, allowing Healthium to broaden the range of solutions it offers while enabling both organisations to serve their respective customer bases with a more comprehensive product line.

Paramount’s scaled manufacturing platform, coupled with its high-quality portfolio, offers a unique value proposition to customers globally. When combined with Healthium’s scale and market reach, this acquisition is expected to unlock opportunities for accelerated commercial expansion, shared R&D and development of differentiated, high-quality innovations.

Paramount brings over three decades of specialised manufacturing expertise and has a global footprint built largely through exports, which account for more than 95% of its revenue. The company serves more than 300 OEM and branded customers across 100+ countries, supported by a complete suite of international product registrations, including EU MDR & USFDA. Paramount manufactures over 250 million devices annually making it one of the largest players in its space. 

Shaily Grover, Managing Director of Paramount Surgimed said, "As we join forces, we will use the broader resources of a larger platform and an expanded portfolio to improve reliability and expand access across the markets we serve.”